FR2628424B1 - Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant - Google Patents

Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant

Info

Publication number
FR2628424B1
FR2628424B1 FR8803064A FR8803064A FR2628424B1 FR 2628424 B1 FR2628424 B1 FR 2628424B1 FR 8803064 A FR8803064 A FR 8803064A FR 8803064 A FR8803064 A FR 8803064A FR 2628424 B1 FR2628424 B1 FR 2628424B1
Authority
FR
France
Prior art keywords
chromannol
obtaining
pharmaceutical compositions
compositions containing
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8803064A
Other languages
English (en)
Other versions
FR2628424A1 (fr
Inventor
Georges Garcia
Richard Roux
Dino Nisato
Patrick Gautier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR8803064A priority Critical patent/FR2628424B1/fr
Priority to FI882945A priority patent/FI90343C/fi
Priority to IL86798A priority patent/IL86798A/xx
Priority to NZ225117A priority patent/NZ225117A/xx
Priority to DK343388A priority patent/DK343388A/da
Priority to PT87788A priority patent/PT87788B/pt
Priority to NO882762A priority patent/NO170216C/no
Priority to EP88401580A priority patent/EP0296975A1/fr
Priority to JP63155989A priority patent/JPS6426578A/ja
Priority to KR1019880007608A priority patent/KR890000470A/ko
Publication of FR2628424A1 publication Critical patent/FR2628424A1/fr
Application granted granted Critical
Publication of FR2628424B1 publication Critical patent/FR2628424B1/fr
Priority to US08/019,314 priority patent/US5284838A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8803064A 1987-06-23 1988-03-09 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant Expired - Fee Related FR2628424B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8803064A FR2628424B1 (fr) 1988-03-09 1988-03-09 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant
FI882945A FI90343C (fi) 1987-06-23 1988-06-20 Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
IL86798A IL86798A (en) 1987-06-23 1988-06-20 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
NZ225117A NZ225117A (en) 1987-06-23 1988-06-21 Trans -2,2-dimethylchroman-3-ol derivatives and pharmaceutical compositions
PT87788A PT87788B (pt) 1987-06-23 1988-06-22 Processo para a preparacao de derivados do 2,2-dimetil-3-cromanol que tem actividade anti-hipertensiva e anti-arritmica
NO882762A NO170216C (no) 1987-06-23 1988-06-22 Analogifremgangsmaate for fremstilling av antihypertensiveog antiarytmiske kromanolderivater
DK343388A DK343388A (da) 1987-06-23 1988-06-22 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler
EP88401580A EP0296975A1 (fr) 1987-06-23 1988-06-23 Dérivés du diméthyl-2,2 chromannol-3, procédé d'obtention et compositions pharmaceutiques les contenant
JP63155989A JPS6426578A (en) 1987-06-23 1988-06-23 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
KR1019880007608A KR890000470A (ko) 1987-06-23 1988-06-23 2,2-디메틸크로만-3-올 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
US08/019,314 US5284838A (en) 1987-06-23 1993-02-18 Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8803064A FR2628424B1 (fr) 1988-03-09 1988-03-09 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant

Publications (2)

Publication Number Publication Date
FR2628424A1 FR2628424A1 (fr) 1989-09-15
FR2628424B1 true FR2628424B1 (fr) 1990-12-28

Family

ID=9364110

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8803064A Expired - Fee Related FR2628424B1 (fr) 1987-06-23 1988-03-09 Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant

Country Status (1)

Country Link
FR (1) FR2628424B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
EP0172352B1 (fr) * 1984-06-22 1990-08-29 Beecham Group Plc Composés benzopyranniques actifs

Also Published As

Publication number Publication date
FR2628424A1 (fr) 1989-09-15

Similar Documents

Publication Publication Date Title
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2466248B1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
FR2665898B1 (fr) Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23753A1 (fr) Procede de preparation de derives de piperidine nouveaux et de compositions pharmaceutiques contenant ces composes
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
FR2642065B1 (fr) Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
FR2621587B1 (fr) Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
FR2599034B1 (fr) Derives de 1-(hydroxystyryl)-5h-2,3,-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant
PT84452B (fr) Procede de preparation de derives de n-](hydroxy-2 phenyl) (phenyl) methylene"amino-2 ethyl"acetamide et de compositions pharmaceutiques les contenant
MA21588A1 (fr) Derives d'ether de n-pheryl pyrazole-4-yle, compositions les contenant et leur procede de preparation.
MC2050A1 (fr) Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication
PT82364A (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
FR2693722B1 (fr) Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2625744B1 (fr) Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant
FR2628424B1 (fr) Derives du dimethyl-2,2 chromannol-3 procede d'obtention et compositions pharmaceutiques en contenant
BE884716A (fr) Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes
FR2645864B1 (fr) Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2622194B1 (fr) Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
ST Notification of lapse